J&J Resolves ADHD Lawsuit with Impax Labs and Teva

Johnson & Johnson (J&J) have established a new deal to settle a patent disagreement regarding their attention-deficit hyperactivity disorder (ADHD) drug, Concerta. Impax Laboratories and partner Teva Pharmaceutical Industries launched a lawsuit against Johnson & Johnson’s Janssen Pharmaceuticals and Alza Corp units.  Impax Laboratories announced on Friday that the lawsuit has now been settled after

Continue Reading